Under which circumstances would you prefer ropeginterferon over hydroxyurea for patients with Polycythemia Vera?
Ropeginterferon is now a preferred therapy for Polycythemia Vera (PV) as per a recent update to the NCCN guidelines.
Community PollStarted
When do you use hydroxyurea for cytoreductive therapy in polycythemia vera?
13 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Hematology · Johns Hopkins University
Answered on · Updated on
The approval of ropeginterferon (Besremi) for the treatment of polycythemia vera (PV) without any restrictions was a welcome event for PV patients and their physicians. First, because this drug selectively targets the JAK2-mutated hematopoietic stem cell (HSC) responsible for PV and can produce comp...
Join for free or sign in to see the full answer